Maravai LifeSciences Holdings, Inc. is a life sciences company providing critical products to enable the development of drug therapies, diagnostics and novel vaccines and to support research on human diseases. Its segments include Nucleic Acid Production Segment and Biologics Safety Testing Segment. The Nucleic Acid Production segment is focused on the manufacturing and sale of highly modified nucleic acids products to support the needs of customers’ research, therapeutic and vaccine programs. This segment’s business units include TriLink Discovery, TriLink GMP, Glen Research and Alphazyme. The Biologics Safety Testing segment is focused on manufacturing and selling biologics safety and impurity tests and assay development services that are utilized by its customers in their biologic drug manufacturing activities. This segment’s business is comprised of Cygnus Technologies. It serves various companies, including biopharmaceutical, vaccine, diagnostics and cell and gene therapy.
Mã chứng khoánMRVI
Tên công tyMaravai LifeSciences Holdings Inc
Ngày IPONov 20, 2020
Giám đốc điều hànhMr. Bernd Brust
Số lượng nhân viên570
Loại chứng khoánOrdinary Share
Kết thúc năm tài chínhNov 20
Địa chỉ10770 Wateridge Circle Suite 200
Thành phốSAN DIEGO
Sàn giao dịch chứng khoánNASDAQ Global Select Consolidated
Quốc giaUnited States of America
Mã bưu điện92121
Điện thoại18585460004
Trang webhttps://www.maravai.com/
Mã chứng khoánMRVI
Ngày IPONov 20, 2020
Giám đốc điều hànhMr. Bernd Brust
Tổng cộng
0.00
USD đã được phân phối dưới dạng cổ tức trong 5 năm qua.

Không có dữ liệu